Filing Details
- Accession Number:
- 0001209191-18-036517
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-07 19:40:27
- Reporting Period:
- 2018-06-05
- Accepted Time:
- 2018-06-07 19:40:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 906709 | Nektar Therapeutics | NKTR | Pharmaceutical Preparations (2834) | 943134940 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 936728 | A Roy Whitfield | C/O Nektar Therapeutics 455 Mission Bay Boulevard South San Francisco CA 94158 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-05 | 1,600 | $55.22 | 173,600 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-06-06 | 2,000 | $59.07 | 175,600 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-06-06 | 1,400 | $59.80 | 177,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 20,000 | Indirect | by Family Trust |
Billionaire Hedge Funds
